Trial Profile
Retrospective, multicentre study of characterized the pharmacokinetics of raltegravir in HIV-infected liver transplant patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 04 Feb 2016 New trial record
- 10 Jan 2016 Results published in the Journal of Antimicrobial Chemotherapy